Billionaire and Founder of Neuralink, Elon Musk on his X/Twitter page said the first human received the initial brain implant last Sunday and is now recovering well.
The US Food and Drug Administration (FDA) gave the company permission last year to conduct its first trial of testing its implantable chip in humans.
According to Musk, preliminary results show effective detection of neurons.
The initial Prime Study is an attempt to demonstrate wireless brain-computer connectivity to assess the safety of implantable and surgical robots.
According to the company's website, the study will also evaluate its functionality for people with quadriplegia or paralysis of all four limbs. In addition, it can also control the human thinking device.
However, Reuters media reported earlier this month that Neuralink was fined for violating US Department of Transportation (DoT) regulations regarding the use of hazardous moving materials.
During an inspection of the company's facilities in Texas and California in February 2023, experts from the DoT found that the company had failed to register itself as a user of hazardous materials.
Based on a statement from the US Centers for Disease Control and Prevention, they found improper packaging of hazardous waste including the flammable liquid Xylene. The liquid can cause pain, dizziness, confusion, loss of muscle coordination and even death.
Neuralink received FDA approval last year for its first attempt at testing the company's implant in humans and it was a major human technology milestone.
Reuters also reported that the company will be worth $5 billion in June based on the value of private equity trading.
Neuralink announced the implant trial last September and the research robot will perform 'ultra-fine' thread surgery to help send signals to the patient's brain.
